Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan
PolandStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
PolandLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
PolandStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
PolandStudy of NT 201 compared to placebo in adults with moderate to severe platysma prominence
PolandStudy of aneratrigine mesilate (iN1011-N17-02) to find the best dose for treating pain in adults with post-herpetic neuralgia
PolandStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
PolandStudy of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years
PolandStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
PolandStudy of CIT-013 at Three Different Doses for Patients with Moderately Active Rheumatoid Arthritis
PolandEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
PolandStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
